Table 1.
Neuroanatomical Measure | Disease State/Condition | Reported Effect Size |
---|---|---|
Hippocampal volume | Temporal lobe epilepsy | 10–33%14 |
Alzheimer’s disease | 22%30 | |
Mild cognitive impairment | 14%30 | |
Stroke | 19–32%31 | |
Depression | 19%32 | |
Healthy aging (age 40 to 75) | 16%33 | |
Cortical thickness | Alzheimer’s disease | 11.7% (.5 mm)34 |
Mild cognitive impairment | 3.7% (.16 mm)34 | |
Attention-deficit hyperactivity disorder | 1.9% (.09 mm)29 | |
Schizophrenia | 3.5% (.09 mm)35 | |
Brain volume | Chronic alcoholism | 5.9%36 |
Schizophrenia | 1.5%37 | |
Childhood lead exposure | 1.2%38 | |
Alzheimer’s disease | .98% per year15 |
All estimates in patient groups are reduced relative to healthy controls. Similarly, healthy aging is associated with reduced hippocampal volume between ages 45 and 60 and >75 years old. Percentage changes are either provided as reported or estimated from reported absolute values as .